Ever tried. Ever failed. No matter. The CFMATTERS study and the future of microbiome-directed trials in cystic fibrosis
- PMID: 40780850
- DOI: 10.1183/13993003.01122-2025
Ever tried. Ever failed. No matter. The CFMATTERS study and the future of microbiome-directed trials in cystic fibrosis
Conflict of interest statement
Conflict of interest: M. Mac Aogáin reports consultancy fees from Agence Nationale de la Recherche (ANR), payment or honoraria for lectures, presentations, manuscript writing or educational events from XII International Workshop on Lung Health 2025 (PUBLI CREATIONS SAM – Lena Group) and the following financial (or non-financial) interests: a donation paid to institution from Pfizer Healthcare Ireland in support of genetic diagnostic services.
Comment on
- 
  
  Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial.Eur Respir J. 2025 Aug 8;66(2):2402443. doi: 10.1183/13993003.02443-2024. Print 2025 Aug. Eur Respir J. 2025. PMID: 40506211 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
- Full Text Sources
 
        